Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of heterozygosity and copy number alterations in flow-sorted bulky cervical cancer.

PloS one - 1 Jan 2013

van den Tillaart Sabrina A H M, Corver Wim E, Ruano Neto Dina, ter Haar Natalja T, Goeman Jelle J, Trimbos J Baptist M Z, Fleuren Gertjan J, Oosting Jan

Abstract excerpt

Treatment choices for cervical cancer are primarily based on clinical FIGO stage and the post-operative evaluation of prognostic parameters including tumor diameter, parametrial and lymph node involvement, vaso-invasion, infiltration depth, and histological type. The aim of this study was to evaluate genomic changes in bulky cervical tumors and their relation to clinical parameters, using single nucleotide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chromosome Aberrations

Share to DNA Copy Number Variations

Share to Flow Cytometry

Share to Loss of Heterozygosity

Share to Polymorphism, Single Nucleotide

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 23874418
DOI: 10.1371/journal.pone.0067414
PMCID: PMC3706587

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of heterozygosity and copy number alterations in flow-sorted bulky cervical cancer.PMID 23874418Read ↗

Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations.Semantic proximity Read ↗

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.Semantic proximity Read ↗

Luminal breast epithelial cells from wildtype and <i>BRCA</i> mutation carriers harbor copy number alterations commonly associated with breast cancerSemantic proximity Read ↗

Low-Coverage WGS-Based CIN Scoring Enables Cost-Effective Molecular Stratification and Prognostic Risk Assessment in Laryngeal Squamous Cell CarcinomaSemantic proximity Read ↗

Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinomaSemantic proximity Read ↗

Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.Semantic proximity Read ↗

Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines.Semantic proximity Read ↗

Copy Number–Based Chromosomal Instability Ex-Score Predicts Breast Cancer MalignancySemantic proximity Read ↗

Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.Semantic proximity Read ↗

Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell linesSemantic proximity Read ↗

Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancerSemantic proximity Read ↗

Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.